NeOnc Technologies Holdings Inc

Home
United States
Westlake Village, CA
NeOnc Technologies Holdings Inc

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from NeOnc Technologies Holdings Inc, Medical and health, Westlake Village, CA.

03/27/2025

We’re excited to announce that NeOnc Technologies Holdings, Inc. is now officially trading on the Nasdaq Global Market under the ticker symbol NTHI! Our team celebrated this momentous occasion by ringing the Opening Bell at Nasdaq MarketSite in Times Square. This marks a new chapter in our mission to develop advanced therapeutics for central nervous system disorders. We extend our deepest gratitude to our incredible team, partners, and supporters who have made this possible.
https://www.nasdaq.com/events/neonc-technologies-holdings-inc-rings-opening-bell?utm_source=chatgpt.com
Photo credit: Nasdaq, Inc./ Vanja Savic

02/25/2025

We’ve taken a significant step forward in our mission to advance neuro-oncology by filing a registration statement on Form S-1 with the SEC. As part of this process, we’ve also applied to list on NASDAQ under the ticker symbol NTHI and are awaiting final approval.

Stay tuned as we continue our journey toward becoming a publicly traded company!

02/20/2025

Treating brain diseases has always been a challenge due to the blood-brain barrier—but what if there were a more direct path?

NeOnc Technologies is pioneering a novel approach that leverages the olfactory nerve for targeted drug delivery to the brain. Our platform has the potential to bypass traditional barriers and directly transport therapeutics where they’re needed most.

Now in Phase II trials and granted FDA fast-track status, this breakthrough could open new possibilities for patients facing devastating neurological conditions.

Follow our journey as we push the boundaries of neuro-oncology and beyond!

Learn more: https://bit.ly/3ELeaSK

02/18/2025

NeOnc Technologies Founder & CEO, Dr. Thomas Chen, recently joined Ira Pastor on his show to discuss our pioneering approach to drug delivery for brain cancer and CNS disorders.

With our patented platform technology, we’re exploring a way to bypass the blood-brain barrier and transport therapeutics directly to the brain—potentially unlocking more effective treatments for patients facing these devastating diseases.

A huge thank you to Ira Pastor for the insightful conversation and for shedding light on this important work!

View the full discussion here: https://bit.ly/41jPiu7

02/13/2025

Amir brings decades of entrepreneurial and leadership experience in addition to a proven track record of building and scaling successful businesses. He brings his passion for innovation and strategic growth to his work with Dr. Thomas Chen, collaborating to drive NeOnc Technologies toward success and impactful advancements.

Learn more about Amir and the rest of the team at: https://bit.ly/4b2JNU2

02/11/2025

At Neonc Technologies, we observe and applaud the incredible research efforts dedicated to combating cancer, including groundbreaking work in prevention. Studies show that over 40% of cancer cases and nearly half of cancer deaths are linked to preventable causes. Together, through research, prevention, and collaboration, we can work toward a healthier, cancer-free future.

Learn more: https://bit.ly/3IMn1jI

02/06/2025

Intranasal drug delivery offers a fast, non-invasive way to treat not just respiratory issues but also CNS-based diseases. By bypassing the blood-brain barrier, this method delivers therapeutics directly to the brain via the olfactory or trigeminal nerve pathways, providing targeted treatment with fewer side effects. From FDA-approved seizure control treatments to potential breakthroughs in cancer therapy, intranasal delivery is changing the game in modern medicine.

Learn more here: https://bit.ly/4aLalZH

02/04/2025

This World Cancer Day, we honor the strength, resilience, and courage of cancer patients and their loved ones. At NeOnc Technologies, we remain committed to advancing innovative treatments and bringing hope to those affected by cancer.

To learn more: https://bit.ly/2C4bCMA

01/30/2025

Meet Dr. Thomas Chen, MD, PhD: Founder, CEO & CSO, and Board Director of NeOnc Technologies. Dr. Chen is a board-certified neurosurgeon, Director of Surgical Neuro-Oncology at USC, and a tenured Professor of Neurosurgery and Pathology. With a Ph.D. in pathobiology focusing on immunotherapy for brain tumors, he’s a leading expert in glioma biology and spine cancer surgery. A true pioneer driving innovation in neurosurgery and cancer treatment.

Learn more about Dr. Chen and the rest of the team at: https://bit.ly/3PTAvjr

01/23/2025

Thank you Business Fortune for naming NeOnc as one of the Top 5 biotech companies to watch in 2025.

See more here:
https://bit.ly/4hf6sye

Address

Westlake Village, CA

Telephone

+13109263314

Website

https://neonctech.com/

Alerts

Be the first to know and let us send you an email when NeOnc Technologies Holdings Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to NeOnc Technologies Holdings Inc: